Literature DB >> 8929570

Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome.

C Wójcik1, D Schroeter, S Wilk, J Lamprecht, N Paweletz.   

Abstract

HeLa cells growing in vitro were treated with the peptidyl aldehyde inhibitor of the chymotrypsin-like activity of the proteasome N-benzyloxycarbonyl-Ile-Glu(O-t-butyl)-Ala-leucinal (PSI). Immunofluorescence studies of treated cells revealed the formation of massive perinuclear aggregates rich in ubiquitin and proteasomal antigens, which on the ultrastructural level appeared as perinuclear aggregates of electron-dense material, usually in the vicinity of Golgi cisternae. Histochemical studies disclosed that these cells contained protein-rich perinuclear aggregates detected by amido black staining, while unusual accumulations of lipids, carbohydrates, or nucleic acids were not present. Inhibition of protein synthesis by cycloheximide prevented the formation of aggregates, whereas microtubule disruption by nocodazole induced a dispersion of the aggregates. We hypothesize that aggregates induced by PSI treatment correspond to accumulations of proteasome-substrate complexes in a well-defined region, where the proteolytic processes of the ubiquitin-proteasome pathway seem to be somehow centered. We propose to call this region the proteolysis center.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929570

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  42 in total

Review 1.  Aggresomes and Russell bodies. Symptoms of cellular indigestion?

Authors:  R R Kopito; R Sitia
Journal:  EMBO Rep       Date:  2000-09       Impact factor: 8.807

2.  Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.

Authors:  L Stefanis; K E Larsen; H J Rideout; D Sulzer; L A Greene
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 3.  Protein quality control during erythropoiesis and hemoglobin synthesis.

Authors:  Eugene Khandros; Mitchell J Weiss
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

4.  Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.

Authors:  Liewei Wang; Tien V Nguyen; Richard W McLaughlin; Laura A Sikkink; Marina Ramirez-Alvarado; Richard M Weinshilboum
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

5.  Expression of mutant Ins2C96Y results in enhanced tubule formation causing enlargement of pre-Golgi intermediates of CHO cells.

Authors:  Jing-Yu Fan; Jürgen Roth; Christian Zuber
Journal:  Histochem Cell Biol       Date:  2007-07-24       Impact factor: 4.304

6.  Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation.

Authors:  Krista Rantanen; Juha Pursiheimo; Heidi Högel; Virpi Himanen; Eric Metzen; Panu M Jaakkola
Journal:  Mol Biol Cell       Date:  2008-03-12       Impact factor: 4.138

7.  Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery.

Authors:  Yan Wang; Anatoli B Meriin; Nava Zaarur; Nina V Romanova; Yury O Chernoff; Catherine E Costello; Michael Y Sherman
Journal:  FASEB J       Date:  2008-10-14       Impact factor: 5.191

8.  The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones.

Authors:  Jenny Fortun; Jonathan D Verrier; Jocelyn C Go; Irina Madorsky; William A Dunn; Lucia Notterpek
Journal:  Neurobiol Dis       Date:  2006-12-13       Impact factor: 5.996

9.  Are proteasomes involved in the formation of the kinetochore?

Authors:  N Paweletz; C Wójcik; D Schroeter; E M Finze
Journal:  Chromosome Res       Date:  1996-09       Impact factor: 5.239

Review 10.  Protein quality control in neurodegeneration: walking the tight rope between health and disease.

Authors:  E M Hol; W Scheper
Journal:  J Mol Neurosci       Date:  2007-03-24       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.